ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Fufang Zhenzhu Tiaozhi (FTZ) capsule ameliorates diabetes-accelerated atherosclerosis via suppressing YTHDF2-mediated m6A modification of SIRT3 mRNA

Zhang, Yue; Wang, Ruonan; Tan, Huiling; Wu, Kaili; Hu, Yaju; Diao, Hongtao; Wang, Dongwei; Tang, Xinyuan; Leng, Mingyang; Li, Xu; Cai, Zhenlu; Luo, Duosheng; Shao, Xiaoqi; Yan, Meiling; Chen, Yingyu; Rong, Xianglu; Guo, Jiao*广东药学院
Journal of Ethnopharmacology2023-12-5DOI: 10.1016/j.jep.2023.116766
1被引5阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Fufang Zhenzhu TiaoZhi (FTZ), a Chinese medicinal decoction, has continuously been used to treat metabolic syndrome. Atherosclerosis is the main pathological basis of cardiovascular disease. The N6 methyladenosine (m6A) modification is a highly dynamic and reversible process involving a variety of important biological processes.Aim of the study: Here, we investigated the therapeutic effects and mechanism of FTZ in diabetes-accelerated atherosclerosis.Materials and methods: Doppler ultrasonography was used to examine the carotid intima-media thickness and plaque area in diabetic atherosclerosis patients. HFD mice were injected with streptozotocin to induce diabetes. HE and Oil red O staining were used to assess the effect of FTZ on lipid deposition. HUVECs were induced with HG/ox-LDL as a model of diabetic atherosclerosis. Furthermore, application of m6A methylation level kit, qRTPCR, Western blot, tunel staining, reactive oxygen species staining and mPTP staining were performed to analyze the detailed mechanism. Results: Clinical trials of FTZ have shown obvious effect of lowering blood glucose and blood lipids. These effects were reversed after FTZ intervention. Compared with the control, lipid deposition decreased significantly after FTZ administration. FTZ reduced endothelial cell apoptosis. At the same time, we found that FTZ reversed the increase of methylation reader YTHDF2 caused by ox-LDL treatment. Subsequently, we discovered that YTHDF2 degraded SIRT3 mRNA, leading to endothelial cell apoptosis and oxidative stress.Conclusion: FTZ attenuated diabetes-accelerated atherosclerosis by decreasing blood glucose and serum lipids levels, and increased endothelial cell antioxidant capacity, inhibited endothelial cell apoptosis via inhibiting YTHDF2-mediated m6A modification of SIRT3 mRNA, which reduced mRNA degradation.

学科与关键词

关键词
Fufang Zhenzhu TiaoZhiDiabetes-accelerated atherosclerosism 6 A RNA methylationYTHDF2SIRT3
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2023-12-05
卷期
第 317 卷
页码
116766
DOI
10.1016/j.jep.2023.116766
语言
ENGLISH
成果收录
SCIE
资助标注
Key Project of National Natural Science Foundation of China [81830113]; National key R amp; D pro-gram of China "Research on modernization of traditional Chinese med-icine" [2018YFC1704200]; Major basic applied basic research projects of Guangdong Province of China [2019B030302005]; Youth Innovation Talents Project of Colleges and Universities in Guangdong Province [2019KQNCX058]

作者

  • Z

    Zhang, Yue (第一作者)

    guangdong pharmaceut univ

  • W

    Wang, Ruonan

    guangdong pharmaceut univ

查看全部 17 位作者收起作者
  • T

    Tan, Huiling

    guangdong pharmaceut univ

  • W

    Wu, Kaili

    guangdong pharmaceut univ

  • H

    Hu, Yaju

    guangdong pharmaceut univ

  • D

    Diao, Hongtao

    guangdong pharmaceut univ

  • W

    Wang, Dongwei

    guangdong pharmaceut univ

  • T

    Tang, Xinyuan

    guangdong pharmaceut univ

  • L

    Leng, Mingyang

    guangdong pharmaceut univ

  • L

    Li, Xu

    guangdong pharmaceut univ

  • C

    Cai, Zhenlu

    guangdong pharmaceut univ

  • L

    Luo, Duosheng

    guangdong pharmaceut univ

  • S

    Shao, Xiaoqi

    guangdong pharmaceut univ

  • Y

    Yan, Meiling

    guangdong pharmaceut univ

  • C

    Chen, Yingyu

    guangdong pharmaceut univ

  • R

    Rong, Xianglu

    guangdong pharmaceut univ

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417